期刊文献+

28例造血干细胞移植术后早期感染的临床研究 被引量:3

Nosocomial infection in early stage following hemopoietic stem cell transplantation: Clinical report and analysis in 28 cases
下载PDF
导出
摘要 目的:探讨造血干细胞移植( HSCT)术后早期感染的临床特点。方法:回顾性分析2012年4月~2015年10月我院收治的28例各种类型造血干细胞移植病例早期感染的发生和治疗情况。结果:28例患者在移植早期27例(96.4%)发生了不同程度的感染,发生中位时间6.9 d。异基因造血干细胞移植(Allo-HSCT)与自体造血干细胞移植(Auto-HSCT)发生感染率无显著差别,重症感染率差异有统计学意义( P<0.05)。结论:HSCT后早期感染发生率高,临床尤其要注重Allo-HSCT后早期感染的预防、鉴别和治疗。 Objective:To investigate the ward infection features in patients in the early stage following hematopoietic stem cell transplantation (HSCT). Methods:The incidences and management strategies were reviewed in 28 cases complicated with ward infections in the early stage after hematopoietic stem cell transplantation between April 2012 and October 2015.Results:Infections occurred in 27 of 28 cases(96.4%) following transplantation.The median time for infection was 6.9 days(mean:10.8 d).The infection was not significantly different in patients received Allo-HSCT or Auto-HSCT,yet was signifi-cant in cases with severe infection(P〈0.05).Conclusion:Infection is a major complication in early stage following HSCT,and patients received Allo-HSCT may be complicated with severe infection,which requires special attention,identification and timely management.
出处 《皖南医学院学报》 CAS 2016年第6期562-565,共4页 Journal of Wannan Medical College
关键词 造血干细胞移植术 病原菌 重症感染 血流 hematopoietic stem cell transplantation pathogens severe infection bloodstream
  • 相关文献

参考文献4

二级参考文献23

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2[1]Weaver, CH, Schwartzberg LS, Hainsworth J. Et al. Treatment-related mortality in 1000 consecuive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancers[J]. Bone Marrow Transplant, 1997, 19(7): 671.
  • 3[2]Kruger W, Russmann B, Kroger N, et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation-a 7 year single centre investigation of 409 cases[J]. Bone Marrow Transplant, 1999, 23(6): 589.
  • 4[3]Mossad SB, Longworth DL, Goormastic M, et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients[J]. Bone Marrow Transplant, 1996, 18(2): 265.
  • 5[4]Engels EA, Ellis CA, Supran SE, et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk[J]. Clin Inf Dis, 1999, 28(2): 256.
  • 6Huang XJ,Shen ZX,Wang C,et al.Clinical guidelines for management of cancer patients with neutropenia and unexplained fever.Int J Antimicrob Agents,2005,26S:S128-132.
  • 7Karthaus M,Cornely OA.Recent developments in the management of invasive fungal infections in patients with hematological malignancies.Ann Hematol,2005,84:207-216.
  • 8Odabasi Z,Mattiuzzi G,Estey E,et al.Beta-D-glucan as a diagnostic adjunct for invasive fungal infections:validation,cutoff development,and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.Clin Infect Dis,2004,39:199-205.
  • 9Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med,2003,348:1546-1554.
  • 10Bhatti Z,Shaukat A,Almyroudis NG,et al.Review of epidemiology,diagnosis,and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.Mycopathogia,2006,162:1-15.

共引文献37

同被引文献20

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部